[Transdermal beta blockers: effect on 24-hour blood pressure profile in hypertensive patients]. 1987

C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001795 Blood Pressure Determination Techniques used for measuring BLOOD PRESSURE. Blood Pressure Determinations,Determination, Blood Pressure
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
January 1991, Journal of cardiovascular pharmacology,
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
September 1996, International journal of clinical pharmacology and therapeutics,
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
January 2014, Kardiologia polska,
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
February 2008, Journal of clinical hypertension (Greenwich, Conn.),
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
May 1998, Hypertension (Dallas, Tex. : 1979),
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
September 2002, Journal of hypertension,
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
December 1995, Hypertension (Dallas, Tex. : 1979),
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
January 1989, Medicina,
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
December 1994, American journal of hypertension,
C Spieker, and W Vetter, and S Hany, and R Liedke, and H Vetter
August 1990, Klinische Wochenschrift,
Copied contents to your clipboard!